Cargando…
Corrigendum: Case Report: Durable response to immuno-chemotherapy in a case of ROS1 fusion-positive advanced lung adenocarcinoma: A case report
| Autores principales: | , , , , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Frontiers Media S.A.
2023
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10415062/ https://www.ncbi.nlm.nih.gov/pubmed/37576810 http://dx.doi.org/10.3389/fphar.2023.1256801 |
| _version_ | 1785087438020935680 |
|---|---|
| author | Yan, Ningning Huang, Siyuan Li, Linlin Guo, Qianqian Geng, Di Zhang, Huixian Guo, Sanxing Li, Xingya |
| author_facet | Yan, Ningning Huang, Siyuan Li, Linlin Guo, Qianqian Geng, Di Zhang, Huixian Guo, Sanxing Li, Xingya |
| author_sort | Yan, Ningning |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-10415062 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2023 |
| publisher | Frontiers Media S.A. |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-104150622023-08-11 Corrigendum: Case Report: Durable response to immuno-chemotherapy in a case of ROS1 fusion-positive advanced lung adenocarcinoma: A case report Yan, Ningning Huang, Siyuan Li, Linlin Guo, Qianqian Geng, Di Zhang, Huixian Guo, Sanxing Li, Xingya Front Pharmacol Pharmacology Frontiers Media S.A. 2023-07-26 /pmc/articles/PMC10415062/ /pubmed/37576810 http://dx.doi.org/10.3389/fphar.2023.1256801 Text en Copyright © 2023 Yan, Huang, Li, Guo, Geng, Zhang, Guo and Li. https://creativecommons.org/licenses/by/4.0/This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms. |
| spellingShingle | Pharmacology Yan, Ningning Huang, Siyuan Li, Linlin Guo, Qianqian Geng, Di Zhang, Huixian Guo, Sanxing Li, Xingya Corrigendum: Case Report: Durable response to immuno-chemotherapy in a case of ROS1 fusion-positive advanced lung adenocarcinoma: A case report |
| title | Corrigendum: Case Report: Durable response to immuno-chemotherapy in a case of ROS1 fusion-positive advanced lung adenocarcinoma: A case report |
| title_full | Corrigendum: Case Report: Durable response to immuno-chemotherapy in a case of ROS1 fusion-positive advanced lung adenocarcinoma: A case report |
| title_fullStr | Corrigendum: Case Report: Durable response to immuno-chemotherapy in a case of ROS1 fusion-positive advanced lung adenocarcinoma: A case report |
| title_full_unstemmed | Corrigendum: Case Report: Durable response to immuno-chemotherapy in a case of ROS1 fusion-positive advanced lung adenocarcinoma: A case report |
| title_short | Corrigendum: Case Report: Durable response to immuno-chemotherapy in a case of ROS1 fusion-positive advanced lung adenocarcinoma: A case report |
| title_sort | corrigendum: case report: durable response to immuno-chemotherapy in a case of ros1 fusion-positive advanced lung adenocarcinoma: a case report |
| topic | Pharmacology |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10415062/ https://www.ncbi.nlm.nih.gov/pubmed/37576810 http://dx.doi.org/10.3389/fphar.2023.1256801 |
| work_keys_str_mv | AT yanningning corrigendumcasereportdurableresponsetoimmunochemotherapyinacaseofros1fusionpositiveadvancedlungadenocarcinomaacasereport AT huangsiyuan corrigendumcasereportdurableresponsetoimmunochemotherapyinacaseofros1fusionpositiveadvancedlungadenocarcinomaacasereport AT lilinlin corrigendumcasereportdurableresponsetoimmunochemotherapyinacaseofros1fusionpositiveadvancedlungadenocarcinomaacasereport AT guoqianqian corrigendumcasereportdurableresponsetoimmunochemotherapyinacaseofros1fusionpositiveadvancedlungadenocarcinomaacasereport AT gengdi corrigendumcasereportdurableresponsetoimmunochemotherapyinacaseofros1fusionpositiveadvancedlungadenocarcinomaacasereport AT zhanghuixian corrigendumcasereportdurableresponsetoimmunochemotherapyinacaseofros1fusionpositiveadvancedlungadenocarcinomaacasereport AT guosanxing corrigendumcasereportdurableresponsetoimmunochemotherapyinacaseofros1fusionpositiveadvancedlungadenocarcinomaacasereport AT lixingya corrigendumcasereportdurableresponsetoimmunochemotherapyinacaseofros1fusionpositiveadvancedlungadenocarcinomaacasereport |